Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$558.65M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$555.16M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$567.12M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$576.52M
Current Ratio
7.19
TTM Avg
3.91
3Y Avg
2.77
5Y Avg
2.56
Market Cap
$540.95M
Current Ratio
9.83
TTM Avg
11.46
3Y Avg
6.57
5Y Avg
5.79
Market Cap
$538.58M
Current Ratio
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $558.65M | 3.46 | 4.63 | 6.00 | 6.13 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | 5.42 | 12.18 | 12.18 | 12.18 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | 1.68 | 2.23 | 2.63 | 2.59 |
| CorMedix Inc. (CRMD)vs › | $566.03M | 2.56 | 2.75 | 5.48 | 7.66 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | 9.36 | 2.17 | 1.76 | 2.63 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | 7.19 | 3.91 | 2.77 | 2.56 |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | 9.83 | 11.46 | 6.57 | 5.79 |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | 25.13 | 6.17 | 7.34 | 19.91 |
| ProKidney Corp. (PROK)vs › | $538.01M | 8.36 | 10.03 | 20.35 | 14.11 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
